Healthcare Technology Startup Raises $38 Million to Support AI Platform

A major healthcare technology startup has secured a significant funding boost to support its innovative AI platform that flags hospital patients who may be in need of a closer examination.

Healthleap, founded by siblings Jemima and Josiah Meyer in South Africa in 2022, raised $38 million in seed and Series A funding. The company's initial product was a clinical nutrition tool created by Jemima for dietitians. However, Healthleap later shifted its focus to developing a more comprehensive platform.

This new platform uses artificial intelligence to analyze patient data from hospital records, identifying patients who may be suffering from conditions such as malnutrition or delirium that are often overlooked. The AI technology extracts relevant information from clinicians' written notes in patient charts.

According to Healthleap's CEO and co-founder Josiah Meyer, the company's platform is currently deployed in more than 50 hospitals worldwide. These institutions use the tool to screen patients for various conditions, including malnutrition and delirium.

The startup has also developed programs to identify aspiration pneumonia, pressure ulcers, and risk of readmission for congestive heart failure, although these are still undergoing clinical validation.

Healthleap's AI-powered platform analyzes electronic health records to identify patients who may be at risk of undiagnosed conditions or illnesses. The system uses language models to extract relevant information from written notes, such as weight loss or difficulty swallowing, and combines it with structured data like lab reports and vital signs.

The resulting analysis is then fed into the company's risk models, which highlight patients who require a closer look. This process is automated, occurring every night for all adult inpatients, and yielding a risk score that is integrated into the care team's workflow the following morning.

Malnutrition has proven to be a particularly useful focus area for Healthleap, as it often goes undiagnosed but can significantly impact patient recovery. Research suggests that between 20% and 50% of hospital inpatients are malnourished, with associated complications including longer stays, impaired wound healing, infections, and higher morbidity and mortality.

The company has experienced significant growth over the past year, expanding from three hospital partners to more than 50. This includes major healthcare institutions like Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare, which have all adopted Healthleap's platform.

Healthleap's revenue has also seen a substantial increase, with growth exceeding tenfold over the same period. While specific figures are not disclosed, this rapid expansion underscores the growing interest in AI-powered healthcare solutions that can help prevent missed diagnoses and improve patient outcomes.

Healthleap's innovative approach to healthcare has led to significant financial gains for its clients. The company's AI-powered solutions have resulted in substantial returns on investment for hospitals, with some seeing a 5x or even 20x return on their contract price.

One notable example of Healthleap's success is the malnutrition program it implemented at the Hospital of the University of Pennsylvania. This initiative yielded an impressive annualized financial impact of $23.8 million, with $6.3 million coming from additional reimbursement and $17.5 million from shorter hospital stays.

Healthleap's business model is designed to provide hospitals with a clear return on investment. The company uses outcome-based pricing, where the hard ROI is validated by the hospital finance team and used to contractually ensure that Healthleap delivers multiples of the contract price.

The startup plans to invest its recent funding in key areas such as engineering, product development, sales, and customer success. This will enable Healthleap to expand its capabilities and support the identification of more health conditions, ultimately aiming to cover over 40 major health conditions.

As part of its growth strategy, Healthleap also intends to explore new markets beyond inpatient care, including outpatient and home care settings. By doing so, the company aims to further improve patient outcomes and provide hospitals with a comprehensive suite of AI-powered healthcare solutions.

Healthleap, a company that uses AI to identify hospital patients who may require closer monitoring, has secured $38 million in funding.

This investment will enable Healthleap to further develop its technology and expand its reach into more hospitals. By doing so, the company aims to improve patient outcomes and provide healthcare institutions with a comprehensive suite of AI-powered solutions. This could potentially lead to better care for patients and reduced costs for hospitals.

Healthleap's technology uses machine learning algorithms to analyze patient data and identify those who may be at risk of complications or require additional attention. The company has already made significant progress in this area, but the new funding will allow it to refine its approach and integrate its solutions with existing hospital systems.